Q3 2026 13F filing
Updated 6 days ago48 disclosed positions worth $2.3B
Full holdings
Every line item disclosed in Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | R REVOLUTION MEDICINES INC | $529M | 2.58M | 23.04% | — |
| 2 | R RELAY THERAPEUTICS INC | $289.4M | 16.04M | 12.61% | — |
| 3 | W GENEDX HOLDINGS CORP | $268M | 3.71M | 11.68% | — |
| 4 | B BIOLIFE SOLUTIONS INC | $174.8M | 4.50M | 7.62% | — |
| 5 | I ILLUMINA INC | $145.1M | 530.0K | 6.32% | — |
| 6 | G GRAIL INC | $95.3M | 680.0K | 4.15% | — |
| 7 | T 10X GENOMICS INC | $94.9M | 1.05M | 4.13% | — |
| 8 | L STANDARD BIOTOOLS INC | $65.8M | 88.78M | 2.86% | — |
| 9 | N NEUROGENE INC | $44.1M | 1.59M | 1.92% | — |
| 10 | S SCHOLAR ROCK HLDG CORP | $41.1M | 850.0K | 1.79% | — |
| 11 | P PERSONALIS INC | $37.4M | 2.30M | 1.63% | — |
| 12 | B BEAM THERAPEUTICS INC | $36.7M | 1.50M | 1.60% | — |
| 13 | T TEMPUS AI INC | $34.7M | 423.6K | 1.51% | — |
| 14 | S SAREPTA THERAPEUTICS INC | $33.2M | 1.82M | 1.44% | — |
| 15 | G GUARDANT HEALTH INC | $33M | 185.0K | 1.44% | — |
| 16 | G STRUCTURE THERAPEUTICS INC | $32.2M | 1.03M | 1.40% | — |
| 17 | A ALNYLAM PHARMACEUTICALS INC | $29.6M | 120.0K | 1.29% | — |
| 18 | D DENALI THERAPEUTICS INC | $25.8M | 1.25M | 1.13% | — |
| 19 | H HIMS & HERS HEALTH INC | $23.8M | 800.0K | 1.04% | — |
| 20 | M MAZE THERAPEUTICS INC | $22.9M | 843.9K | 1.00% | — |
| 21 | S SEPTERNA INC | $21.6M | 553.3K | 0.94% | — |
| 22 | P PARABILIS MEDICINES INC | $20.8M | 645.7K | 0.91% | — |
| 23 | A ADLAI NORTYE GROUP LTD | $20M | 1.25M | 0.87% | — |
| 24 | T TAYSHA GENE THERAPIES INC | $19M | 3.90M | 0.83% | — |
| 25 | A AGOMAB THERAPEUTICS NV | $17.2M | 1.55M | 0.75% | — |
| 26 | O ORIC PHARMACEUTICALS INC | $16.8M | 1.25M | 0.73% | — |
| 27 | M MODERNA INC | $14.4M | 75.0K | 0.63% | — |
| 28 | V VERACYTE INC | $12.7M | 276.3K | 0.55% | — |
| 29 | D QUEST DIAGNOSTICS INC | $11.7M | 50.0K | 0.51% | — |
| 30 | B BIOGEN INC | $11.3M | 50.0K | 0.49% | — |
| 31 | E EDGEWISE THERAPEUTICS INC | $10.8M | 265.0K | 0.47% | — |
| 32 | A ABSCI CORPORATION | $10.5M | 973.3K | 0.46% | — |
| 33 | P PRIME MEDICINE INC | $9.7M | 3.17M | 0.42% | — |
| 34 | B BIONTECH SE | $8.4M | 85.0K | 0.36% | — |
| 35 | ? N/A BRAVEHEART BIO INC | $8.1M | 400.0K | 0.35% | — |
| 36 | R RAPPORT THERAPEUTICS INC | $6.7M | 200.0K | 0.29% | — |
| 37 | N INTELLIA THERAPEUTICS INC | $4.3M | 355.0K | 0.19% | — |
| 38 | Q UNIQURE NV | $3.6M | 150.0K | 0.16% | — |
| 39 | C CENTURY THERAPEUTICS INC | $2.1M | 1.23M | 0.09% | — |
| 40 | C CONTINEUM THERAPEUTICS INC | $2M | 148.3K | 0.09% | — |
| 41 | P PACIFIC BIOSCIENCES CALIF IN | $1.7M | 723.8K | 0.07% | — |
| 42 | ? N/A BRIDGEBIO ONCOLOGY THERAPEUT | $1.2M | 282.3K | 0.05% | — |
| 43 | E EDITAS MEDICINE INC | $1.1M | 445.0K | 0.05% | — |
| 44 | M MONTE ROSA THERAPEUTICS INC | $1M | 86.0K | 0.04% | — |
| 45 | ? N/A KARDIGAN INC | $738K | 50.0K | 0.03% | — |
| 46 | R RECURSION PHARMACEUTICALS IN | $683K | 165.3K | 0.03% | — |
| 47 | D GINKGO BIOWORKS HOLDINGS INC | $468K | 36.5K | 0.02% | — |
| 48 | ? N/A TENAYA THERAPEUTICS INC | $218K | 362.0K | 0.01% | — |